Cases & Deals

  • Home
  • Practices
  • Celgene announces $2.9 billion acquisition of Pharmion

Share

Celgene announces $2.9 billion acquisition of Pharmion

August 2008

Client(s) Celgene Corporation

Jones Day advised Celgene Corporation in its $2.9 billion acquisition of Pharmion. In the merger, Pharmion shareholders received in exchange for their stock, Celgene stock and cash.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.